91九色视频

header-logo
Research Bench Lab
Microbiology & Immunology
Amy Hudson, PhD

Amy Hudson, PhD

Professor

Locations

  • Microbiology & Immunology
    BSB B2810

Contact Information

General Interests

Viral Immune Evasion

Education

PhD, Biological and Biomedical Sciences, Harvard University, 1995
Learn more about the Hudson Lab

Research Experience

  • Antigen Presentation
  • Exanthema Subitum
  • Genes, MHC Class I
  • Herpesvirus 6, Human
  • Herpesvirus 7, Human
  • HHV-6
  • HHV-7
  • human CD45
  • insulin-responsive glucose transport
  • membrane trafficking
  • synaptic vesicle recycling
  • viral immune evasion

Research Interests

We are interested in how viruses escape detection by the immune system.

As a response to selective pressures exerted by the host immune system, many viruses have developed an equally complex set of immunoevasive strategies. Perhaps most interesting is the array of unique strategies that viruses employ to interfere with the presentation of viral antigens on the surface of host cells for recognition by cytotoxic T lymphocytes.

Many viruses, including all known members of the Herpesvirus family, target antigen presentation by class I MHC molecules as a means of undermining the anti-viral immune response. We focus on two recently discovered human herpesviruses, HHV-6 and -7. Little is known about the immunobiology of these two beta-herpesviruses. They are most closely related to human cytomegalovirus (HCMV), and like all other herpesviruses, HHV-6 and -7 remain latent or establish persistent infections. Thus, it seemed likely that HHV-6 and -7 would also encode unique mechanisms of immune evasion. Because so many of the viral immunoevasins affect trafficking or stability of class I MHC molecules, we took a biochemical approach to examine the maturation and stability of class I molecules in HHV-7-infected T cells.

Publications

  • (Hess NJ, Turicek DP, Riendeau J, McIlwain SJ, Contreras Guzman E, Nadiminti K, Hudson A, Callander NS, Skala MC, Gumperz JE, Hematti P, Capitini CM.) Sci Adv. 2023 Mar 24;9(12):eadf0567 PMID: 36961891 PMCID: PMC10038349 SCOPUS ID: 2-s2.0-85151044773 03/25/2023

  • (Schneider CL, Whyte ML, Konrad SL, Hudson AW.) J Virol. 2023 Feb 28;97(2):e0189022 PMID: 36688652 PMCID: PMC9973003 SCOPUS ID: 2-s2.0-85149154460 01/24/2023

  • (Weaver GC, Arya R, Schneider CL, Hudson AW, Stern LJ.) Front Immunol. 2022;13:936968 PMID: 35677042 PMCID: PMC9169504 SCOPUS ID: 2-s2.0-85131659986 06/10/2022

  • (Weaver GC, Arya R, Schneider CL, Hudson AW, Stern LJ.) Front Immunol. 2022;13:864898 PMID: 35444636 PMCID: PMC9013968 SCOPUS ID: 2-s2.0-85128490952 04/22/2022

  • (Hess NJ, S Bharadwaj N, Bobeck EA, McDougal CE, Ma S, Sauer JD, Hudson AW, Gumperz JE.) Life Sci Alliance. 2021 Jul;4(7) PMID: 34112724 PMCID: PMC8200291 SCOPUS ID: 2-s2.0-85108045175 06/12/2021

  • (Whyte ML, Smith KA, Buchberger A, Berg Luecke L, Tjan LH, Mori Y, Gundry RL, Hudson AW.) J Virol. 2021 Jun 24;95(14):e0162820 PMID: 33952641 PMCID: PMC8223955 SCOPUS ID: 2-s2.0-85108871238 05/07/2021

  • (Hess NJ, Hudson AW, Hematti P, Gumperz JE.) J Immunol. 2020 Jul 01;205(1):272-281 PMID: 32444392 PMCID: PMC7329317 SCOPUS ID: 2-s2.0-85088373153 05/24/2020

  • (Dirck AT, Whyte ML, Hudson AW.) Mol Biol Cell. 2020 Feb 01;31(3):196-208 PMID: 31851583 PMCID: PMC7001482 SCOPUS ID: 2-s2.0-85081146090 12/19/2019

  • (Hess NJ, Lindner PN, Vazquez J, Grindel S, Hudson AW, Stanic AK, Ikeda A, Hematti P, Gumperz JE.) Front Immunol. 2020;11:573406 PMID: 33193358 PMCID: PMC7604455 SCOPUS ID: 2-s2.0-85094894828 11/17/2020

  • (Zumwalde NA, Sharma A, Xu X, Ma S, Schneider CL, Romero-Masters JC, Hudson AW, Gendron-Fitzpatrick A, Kenney SC, Gumperz JE.) JCI Insight. 2017 Jul 06;2(13) PMID: 28679955 PMCID: PMC5499361 SCOPUS ID: 2-s2.0-85045321193 07/07/2017

  • (Sturgill ER, Malouli D, Hansen SG, Burwitz BJ, Seo S, Schneider CL, Womack JL, Verweij MC, Ventura AB, Bhusari A, Jeffries KM, Legasse AW, Axthelm MK, Hudson AW, Sacha JB, Picker LJ, Früh K.) PLoS Pathog. 2016 Aug;12(8):e1005868 PMID: 27580123 PMCID: PMC5006984 SCOPUS ID: 2-s2.0-84984830187 09/01/2016

  • (Hudson AW.) Curr Opin Virol. 2014 Dec;9:178-87 PMID: 25462451 SCOPUS ID: 2-s2.0-84915759618 12/03/2014

Publications of from the

© 2024 91九色视频.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 91九色视频’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.